Hubei Guangji Pharmaceutical Co., Ltd

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Hubei Guangji Pharmaceutical Co., Ltd

55 YRS

Hubei, China

CNY 347.0 Million

79920 m²

Over 1000 people

Main Products: Riboflavin-5-Phosphate Sodium / Riboflavin (B2) / Pyridoxine

Hubei, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

CDMO

Total Employees

1000+ People

Plant Size

120 Acres

Total Annual Revenue

CNY 690 Million

Production Experience

55+ Years

MAIN
PRODUCTS

1/3

Riboflavin-5-Phosphate Sodium

CAS: 130-40-5

Packing: 10 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

1/3

Riboflavin (B2)

CAS: 83-88-5

Specification: Flake

Packing: 25 KG/Fibre Drum; 20 KG/Fibre Drum; 10 KG/Fibre Drum; 0 KG/Customed Package; 25 KG/Carton

Lead Time: 14-30 days

Inquiry

1/3

Vitamin B6 Feed Grade

CAS: 58-56-0

Packing: 25 KG/Fibre Drum

Lead Time: 14-30 days

Inquiry

ABOUT US

Hubei Guangji Pharmaceutical Co., Ltd

Founded in 1969, Hubei Guangji Pharmaceutical Co., Ltd. is an important holding subsidiary of Hubei Changjiang Industry Investment Group Co., Ltd. Guangji pharmaceutical is headquartered in Wuxue, Hubei Province and listed on Shenzhen Stock Exchange in 1999 (stock code 000952). Over the past 50 years since its establishment and 20 years since its listing, the company has always adhered to the enterprise development spirit of "seeking from top to bottom and daring to be the first" and the enterprise business philosophy of "treating people with sincerity and deacons with faith". It is mainly engaged in the R & D, production and sales of vitamin raw material products. It is a national key high-tech enterprise focusing on the production and sales of medical raw materials and preparations, food additives and feed additives, It governs three production bases, Wuxue, Mengzhou and Xianning. It has established a R & D center with API and preparation as the core and a number of matching subsidiaries. It has developed into a modern pharmaceutical enterprise integrating R & D, production and sales.